The article explores what causes the increase in spending on pharmaceuticals in Sweden. It looks at how new innovative drugs affect this spending. The study found that while the prices of new drugs have stayed steady, the introduction of innovative drugs has led to more people using medications. This means that the price of drugs doesn't have a big impact on overall spending. The researchers suggest that limiting access to new innovative drugs could help reduce the growth in pharmaceutical spending.